Liraglutide significantly attenuated the onset of overt diabetes; none of the LIRA and GH + LIRA rats developed diabetes during the treatment period, compared with a rate of 5/16 (31%) in CON rats (Figure 2B). The gene discussed is GH1; the disease is diabetes mellitus.